The dramatic increase in prevalence and clinical impact of infections caused by carbapenemase-producing Enterobacterales (CPE) are major and ongoing public health problems globally. The carbapenemase groups most commonly encountered include Klebsiella pneumoniae carbapenemase (KPC), New Delhi metallo-β-lactamase (NDM), and OXA-48, with OXA-48 thought to be endemic to North Africa. These enzymes are frequently found on mobile genetic elements and have the potential to be widespread over the world, while the situation in Algeria is not well documented. In this article, we provide an in-depth review of CPE in Algeria, providing up-to-date information on the subject.
Get full access to this article
View all access options for this article.
References
1.
IovlevaA., and DoiY.. 2017. Carbapenem-resistant Enterobacteriaceae. Clin. Lab. Med. 37:303–315.
2.
KellyA.M., MathemaB., and LarsonE.L.. 2017. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int. J. Antimicrob. Agents. 50:127–134.
3.
NordmannP., DortetL., and PoirelL.. 2012. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol. Med. 18:263–272.
4.
MairiA., PantelA., SottoA., LavigneJ.-P, and TouatiA.. 2018. OXA-48-like carbapenemases producing Enterobacteriaceae in different niches. Eur. J. Clin. Microbiol. Infect. Dis. 37:587–604.
5.
PoirelL., HéritierC., TolünV., and NordmannP.. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents. Chemother. 48:15–22.
6.
RozwandowiczM., BrouwerM.S.M, FischerJ., WagenaarJ.A, Gonzalez-ZornB., GuerraB., MeviusD.J, and HordijkJ.. 2018. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J. Antimicrob. Chemother. 73:1121–1137.
7.
BonninR.A., CuzonG., PoirelL., and NordmannP.. 2013. Multidrug-resistant Acinetobacter baumannii clone, France. Emerg. Infect. Dis. 19:822–823.
8.
DecousserJ.W., JansenC., NordmannP., EmirianA., BonninR.A, AnaisL., MerleJ.C, and PoirelL.. 2013. Outbreak of NDM-1-producing Acinetobacter baumannii. in France, January to May 2013. Euro. Surveill. 18: 2, 0547.
9.
AbderrahimA., DjahmiN., PujolC., NedjaiS., BentakoukM.C, Kirane-GacemiD., DekhilM., SottoA., LavigneJ.-P, and PantelA.. 2017. First case of NDM-1-producing Klebsiella pneumoniae in Annaba University Hospital, Algeria. Microb. Drug Resist. 23:895–900.
10.
AgabouA., PantelA., OuchenaneZ., LezzarN., KhemissiS., SattaD., SottoA., and LavigneJ.-P.. 2014. First description of OXA-48-producing Escherichia coli and the pandemic clone ST131 from patients hospitalised at a military hospital in Algeria. Eur. J. Clin. Microbiol. Infect. Dis. 33:1641–1646.
11.
AggouneN., Tali-MaamarH., AssaousF., BenamroucheN., NaimM., and RahalK.. 2014. Emergence of plasmid mediated carbapenemase OXA-48 in a Klebsiella pneumoniae strain in Algeria. J. Glob. Antimicrob. Resist. 2:327–329.
12.
BakourS., SahliF., TouatiA., and RolainJ.-M.. 2015. Emergence of KPC-producing Klebsiella pneumoniae ST512 isolated from cerebrospinal fluid of a child in Algeria. New Microbes New Infect. 3:34–36.
13.
BelbelZ., LalaouiR., BakourS., NedjaiS., DjahmiN., and RolainJ.-M.. 2018. First report of colistin resistance in an OXA-48- and a CTX-M-15 producing Klebsiella pneumoniae clinical isolate in Algeria due to PmrB protein modification and mgrB inactivation. J. Glob. Antimicrob. Resist. 14:158–160.
14.
BouguenounW., BakourS., BentorkiA.A, Al BayssariC., MeradT., and RolainJ.-M.. 2016. Molecular epidemiology of environmental and clinical carbapenemase-producing Gram-negative bacilli from hospitals in Guelma, Algeria: multiple genetic lineages and first report of OXA-48 in Enterobacter cloacae. J. Glob. Antimicrob. Resist. 7:135–140.
15.
BourafaN., ChaalalW., BakourS., LalaouiR., BoutefnouchetN., DieneS.M, and RolainJ.-M.. 2018. Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria. Infect. Drug. Resist. 11:735–742.
16.
CuzonG., BentchoualaC., VogelA., HéryM., LezzarA., SmatiF., DortetL., and NaasT.. 2015. First outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Constantine, Algeria. Int. J. Antimicrob. Agents. 46:725–727.
17.
LeulmiZ., KandouliC., MihoubiI., BenlabedK., LezzarA., and RolainJ.-M.. 2019. First report of blaOXA-24 carbapenemase gene, armA methyltransferase and aac(6′)-Ib-cr among multidrug-resistant clinical isolates of Proteus mirabilis in Algeria. J. Glob. Antimicrob. Resist. 16:125–129.
18.
LoucifL., Kassah-LaouarA., SaidiM., MessalaA., ChelaghmaW., and RolainJ.-M.. 2016. Outbreak of OXA-48-producing Klebsiella pneumoniae involving a sequence type 101 clone in Batna University Hospital, Algeria. Antimicrob. Agents Chemother. 60:7494–7497.
19.
MelloukF.Z., BakourS., MeradjiS., Al-BayssariC., BentakoukM.C, ZouyedF., DjahoudiA., BoutefnouchetN., and RolainJ.M.. 2017. First detection of VIM-4-producing Pseudomonas aeruginosa and OXA-48-producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria. Microb. Drug Resist. 23:335–344.
20.
NabtiL.Z., SahliF., RadjiN., MezaghchaW., SemaraL., AberkaneS., LounnasM., SolassolJ., DidelotM.-N, Jean-PierreH., DumontY., and GodreuilS.. 2019. High prevalence of multidrug-resistant Escherichia coli in urine samples from inpatients and outpatients at a Tertiary Care Hospital in Sétif, Algeria. Microb. Drug Resist. 25:386–393.
21.
RobinF., Aggoune-KhinacheN., DelmasJ., NaimM., and BonnetR.. 2010. Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria. Antimicrob. Agents Chemother. 54:466–470.
22.
SassiA., LoucifL., GuptaS.K, DekhilM., ChettibiH., and RolainJ.-M.. 2014. NDM-5 carbapenemase-encoding gene in multidrug-resistant clinical isolates of Escherichia coli from Algeria. Antimicrob. Agents Chemother. 58:5606–5608.
23.
YousfiH., HadjadjL., DandachiI., LalaouiR., MerahA., AmouraK., DahiA., DekhilM., MessalhiN., DieneS.M, BaronS., and RolainJ.-M.. 2019. Colistin- and Carbapenem-Resistant Klebsiella pneumoniae Clinical_Isolates: algeria. Microb. Drug Resist. 25:258–263.
24.
BachiriT., BakourS., LalaouiR., BelkeblaN., AllouacheM., RolainJ.M, and TouatiA.. 2018. Occurrence of carbapenemase-producing Enterobacteriaceae isolates in the wildlife: first report of OXA-48 in wild boars in Algeria. Microb. Drug Resist. 24:337–345.
25.
BouazizA., LoucifL., AyachiA., GuehazK., BendjamaE., and RolainJ.-M.. 2018. Migratory white stork (Ciconia ciconia): a potential vector of the OXA-48-producing Escherichia coli ST38 clone in Algeria. Microb. Drug Resist. 24:461–468.
26.
Gharout-SaitA., TouatiA., AhmimM., BrasmeL., GuillardT., AgsousA., and de ChampsC.. 2019. Occurrence of carbapenemase-producing Klebsiella pneumoniae in bat guano. Microb. Drug Resist. 25:1057–1062.
27.
LoucifL., Gacemi-KiraneD., CherakZ., ChamlalN., GrainatN., and RolainJ.-M.. 2016. First report of German cockroaches (Blattella germanica) as reservoirs of CTX-M-15 extended-spectrum-β-lactamase- and OXA-48 carbapenemase-producing Enterobacteriaceae in Batna University Hospital, Algeria. Antimicrob. Agents Chemother. 60:6377–6380.
28.
YousfiM., TouatiA., MuggeoA., MiraB., AsmaB., BrasmeL., GuillardT., and de ChampsC.. 2018. Clonal dissemination of OXA-48-producing Enterobacter cloacae isolates from companion animals in Algeria. J. Glob. Antimicrob. Resist. 12:187–191.
29.
YousfiM., TouatiA., MairiA., BrasmeL., Gharout-SaitA., GuillardT., and De ChampsC.. 2016. Emergence of carbapenemase-producing Escherichia coli isolated from companion animals in Algeria. Microb. Drug Resist. 22:342–346.
30.
YousfiM., MairiA., BakourS., TouatiA., HassissenL., HadjadjL., and RolainJ.-M.. 2015. First report of NDM-5-producing Escherichia coli ST1284 isolated from dog in Bejaia, Algeria. New Microbes New Infect. 8:17–18.
31.
MairiA., TouatiA., Ait BessaiS., BoutabtoubY., KhelifiF., SottoA., LavigneJ.-P, and PantelA.. 2019. Carbapenemase-producing Enterobacteriaceae among pregnant women and newborns in Algeria: prevalence, molecular characterization, maternal-neonatal transmission, and risk factors for carriage. Am. J. Infect. Control. 47:105–108.
32.
Rodriguez-MartinezJ.-M., NordmannP., FortineauN., and PoirelL.. 2010. VIM-19, a metallo-beta-lactamase with increased carbapenemase activity from Escherichia coli and Klebsiella pneumoniae. Antimicrob. Agents Chemother. 54:471–476.
33.
YagoubatM., Ould El-Hadj-KhelilA., MalkiA., BakourS., TouatiA., and RolainJ.-M.. 2017. Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria. J. Glob. Antimicrob. Resist. 8:55–59.
34.
TouatiA., MairiA., BaloulY., LalaouiR., BakourS., ThighiltL., GharoutA., and RolainJ.-M.. 2017. First detection of Klebsiella pneumoniae producing OXA-48 in fresh vegetables from Béjaïa city, Algeria. J. Glob. Antimicrob. Resist. 9:17–18.
35.
YaiciL., HaenniM., SarasE., BoudehoucheW., TouatiA., and MadecJ.-Y.. 2016. blaNDM-5-carrying IncX3 plasmid in Escherichia coli ST1284 isolated from raw milk collected in a dairy farm in Algeria. J. Antimicrob. Chemother. 71:2671–2672.
36.
YousfiK., TouatiA., LefebvreB., GarneauP., BrahmiS., Gharout-SaitA., HarelJ., and BekalS.. 2019. Characterization of multidrug-resistant Gram-negative bacilli isolated from hospitals effluents: first report of a blaOXA-48-like in Klebsiella oxytoca, Algeria. Braz. J. Microbiol. 50:175–183.
37.
TafouktR., TouatiA., LeangapichartT., BakourS., and RolainJ.-M.. 2017. Characterization of OXA-48-like-producing Enterobacteriaceae isolated from river water in Algeria. Water Res. 120:185–189.
38.
MairiA., PantelA., OusalemF., SottoA., TouatiA., and LavigneJ.-P.. 2019. OXA-48-producing Enterobacterales in different ecological niches in Algeria: clonal expansion, plasmid characteristics and virulence traits. J. Antimicrob. Chemother. 74:1848–1855.
39.
BalkanI.I., AygünG., AydınS., MutcalıS.I, KaraZ., KuşkucuM., MidilliK., V. Şemen, Ş. Aras, YemişenM., MeteB., R. Özaras, SaltoğluN., TabakF., and R. Öztürk. 2014. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. Int. J. Infect. Dis. 26:51–56.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
